X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry

By Stephen J. Ubl  |    September 28, 2021
I am excited to join with Dr. Michael L. Lomax, President & CEO, UNCF; Dr. James Gillespie, President & Co-Founder, Center for Healthcare Innovation (CHI); and Dr. Chad Womack, Co-Founder and...   Read More

Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda

By Courtney Christian  |    September 27, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.   Read More

Industry leaders discuss the impact of the drug pricing debate

By Brian Newell  |    September 23, 2021
This month, PhRMA hosted a media briefing with leaders within the biopharmaceutical industry to discuss the dangers of current proposals on government price setting, while also sharing alternative...   Read More

PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020

By Tim McClung  |    July 22, 2021
PhRMA member companies’ robust investment in research and development (R&D) has led to advances and discoveries that are transforming health care and our approach to treating patients for a broad...   Read More

Watch: Building trust and enhancing clinical trial diversity

By Andrew Powaleny  |    June 24, 2021
On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA Chief Operating Officer Lori Reilly and Genentech Vice President and Chief...   Read More

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US

By Stephen J. Ubl  |    June 23, 2021
Our industry continues to work tirelessly to combat the COVID-19 virus by developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. As we continue our efforts...   Read More

Researchers to shine light on biopharmaceutical R&D with policymakers

By Andrew Powaleny  |    June 15, 2021
Today, biopharmaceutical researchers from PhRMA member companies are meeting virtually with members of Congress and staff to share their stories of transforming game-changing scientific...   Read More

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

By Abigail Lore  |    March 5, 2021
Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation....   Read More

Coming together to fight COVID-19: A conversation with Paul Perreault, CEO and Managing Director of CSL

By Stephen J. Ubl  |    February 24, 2021
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections.   Read More

Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

By Courtney Christian  |    January 28, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates